"Designing Growth Strategies is in our DNA"

U.S. Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Live Attenuated, mRNA, Viral Vectors, Toxoid, and Others), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Herpes Zoster, and Others}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease and Others}), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Country Forecast, 2023-2030

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI109196

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, By Key Players
    2. Key Industry Developments, By Key Players
    3. New Product Launches, By Key Players
    4. Overview: Technological Advancements in Vaccines Technologies
    5. Impact of COVID-19 on the U.S. Vaccines Market
  5. U.S. Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live attenuated
      4. mRNA
      5. Viral Vectors
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adults
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. GSK plc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Emergent BioSolutions, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. CSL Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Inovio Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Bavarian Nordic
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Mitsubishi Tanabe Pharma Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Vaccines Market Revenue Breakdown (USD Billion, %), By Type, 2022 & 2030

Figure 2: U.S. Vaccines Market Value Share (%), by Type, 2022 & 2030

Figure 3: U.S. Vaccines Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 4: U.S. Vaccines Market Value Share (%), by Disease Indication, 2022 & 2030

Figure 5: U.S. Vaccines Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 6: U.S. Vaccines Market Share (%), By Company, 2022

Table 1: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Type, 2019-2030

Table 2: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Route of Administration, 2019-2030

Table 3: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Disease Indication, 2019-2030

Table 4: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Viral Diseases, 2019-2030

Table 5: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Bacterial Diseases, 2019-2030

Table 6: U.S. Vaccines Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019-2030

U.S. Vaccines Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 90
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase